The current stock price of PRVA is 23.71 USD. In the past month the price decreased by -1.21%. In the past year, price increased by 18.79%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.59 | 100.74B | ||
| CI | THE CIGNA GROUP | 9.69 | 73.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 123.74 | 22.76B | ||
| LH | LABCORP HOLDINGS INC | 15.86 | 20.80B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.78 | 19.30B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.16B | ||
| DVA | DAVITA INC | 12.31 | 8.02B | ||
| HIMS | HIMS & HERS HEALTH INC | 60.13 | 7.39B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.72 | 6.75B | ||
| CHE | CHEMED CORP | 19.45 | 6.06B | ||
| RDNT | RADNET INC | 187.76 | 5.50B | ||
| OPCH | OPTION CARE HEALTH INC | 21.38 | 5.06B |
Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,140 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The firm provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
PRIVIA HEALTH GROUP INC
950 N. Glebe Rd., Suite 700
Arlington VIRGINIA US
CEO: Shawn Morris
Employees: 1140
Phone: 15713668850
Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,140 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The firm provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
The current stock price of PRVA is 23.71 USD. The price decreased by -0.63% in the last trading session.
PRVA does not pay a dividend.
PRVA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
PRVA stock is listed on the Nasdaq exchange.
PRIVIA HEALTH GROUP INC (PRVA) operates in the Health Care sector and the Health Care Providers & Services industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRVA.
ChartMill assigns a technical rating of 5 / 10 to PRVA. When comparing the yearly performance of all stocks, PRVA is one of the better performing stocks in the market, outperforming 71.7% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to PRVA. PRVA has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months PRVA reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 30% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.89% | ||
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| Debt/Equity | 0 |
27 analysts have analysed PRVA and the average price target is 32.18 USD. This implies a price increase of 35.73% is expected in the next year compared to the current price of 23.71.
For the next year, analysts expect an EPS growth of 22% and a revenue growth 20.28% for PRVA